Troy Tevi David
Transaction: 10/01/2025
BUY
Change
+56,000
Price
$2.64
Filing
11/12/2025
Type
BUY
XBiotech Inc.
XBIT • Biotechnology
$2.20
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$67.07M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0Healthy liquidity · 16.01Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.20
Change0.00%
Shares Out30.49M
Market Cap$67.07M
Enterprise Value$-42.45M
52W Range2.09 - 3.61
Beta0.85
P/E-1.49
P/B0.52
P/FCF-1.64
EV/EBITDA0.96
EV/FCF1.04
Price$2.20
Change0.00%
Shares Out30.49M
Market Cap$67.07M
Enterprise Value$-42.45M
52W Range2.09 - 3.61
Beta0.85
P/E-1.49
P/B0.52
P/FCF-1.64
EV/EBITDA0.96
EV/FCF1.04
Earnings Yield-67.29%
FCF Yield-60.88%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio16.01
Quick Ratio16.01
Volume41.56K
Avg Volume30.69K
EPS Surprise-0.21
Investment DNA
How strong this company looks for long-term investors
43
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 16.01Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 3 analyst votes · 2026-09-05
100/100
Bullish
Bullish
3
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Kuendig Thomas Martin
Transaction: 10/01/2025
BUY
Change
+79,115
Price
$2.64
Filing
11/12/2025
Type
BUY
Soffer David Spencer
Transaction: 10/01/2025
BUY
Change
+51,000
Price
$2.64
Filing
11/12/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Troy Tevi David | BUY | +56,000 | $2.64 | 10/01/2025 | 11/12/2025 |
| Kuendig Thomas Martin | BUY | +79,115 | $2.64 | 10/01/2025 | 11/12/2025 |
| Soffer David Spencer | BUY | +51,000 | $2.64 | 10/01/2025 | 11/12/2025 |
| Rademaker Craig Evan | BUY | +92,104 | $2.64 | 10/01/2025 | 11/12/2025 |
| Kuendig Thomas Martin | OTHER | 0 | Not reported | 08/29/2025 | 09/30/2025 |
| Soffer David Spencer | OTHER | 0 | Not reported | 08/29/2025 | 09/30/2025 |
| Troy Tevi David | OTHER | 0 | Not reported | 08/29/2025 | 09/29/2025 |
| Rademaker Craig Evan | OTHER | 0 | Not reported | 08/29/2025 | 09/16/2025 |
| SIMARD JOHN | BUY | +1,026,228 | $3.52 | 03/17/2025 | 03/19/2025 |
| SIMARD JOHN | SELL | -2,470,355 | $4.05 | 01/31/2025 | 02/04/2025 |
| Libby Peter | BUY | +37,500 | $5.12 | 06/20/2024 | 06/21/2024 |
| MacAdam Donald H. | BUY | +37,500 | $5.12 | 06/20/2024 | 06/21/2024 |
| Waldin Jan-Paul | BUY | +37,500 | $5.12 | 06/20/2024 | 06/21/2024 |
| MCKENZIE W THORPE | BUY | +37,500 | $5.12 | 06/20/2024 | 06/21/2024 |
| SIMARD JOHN | BUY | +2,470,355 | $4.05 | 01/03/2024 | 01/05/2024 |
| MCKENZIE W THORPE | BUY | +25,000 | $6.04 | 06/23/2023 | 06/26/2023 |
| MacAdam Donald H. | BUY | +25,000 | $6.04 | 06/23/2023 | 06/26/2023 |
| Libby Peter | BUY | +25,000 | $6.04 | 06/23/2023 | 06/26/2023 |
| Waldin Jan-Paul | BUY | +25,000 | $6.04 | 06/23/2023 | 06/26/2023 |
| HU ANGELA | SELL | -30,000 | $3.84 | 08/10/2023 | 02/23/2023 |